The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Dose intensity and survival outcomes with adjuvant FOLFOX for colon cancer.
Martin Smoragiewicz
No relevant relationships to disclose
Khodadad Rasool Javaheri
No relevant relationships to disclose
Yaling Yin
No relevant relationships to disclose
Sharlene Gill
No relevant relationships to disclose